The global biosurgery market size attained a value of USD 14.4 billion in 2022. The market is anticipated to grow at a CAGR of 7.2% during the forecast period of 2023-2031 to attain a value of USD 26.8 billion by 2031.
Biosurgery Market: Introduction
Biosurgery is a surgical technique that involves the use of various natural or synthetically produced biological materials to aid in the process of surgery and enhance healing. These materials can include surgical sealants, haemostatic agents, adhesion barriers, bone graft substitutes, and soft tissue management solutions, among others.Uses of biosurgery include:
- Haemostasis: Haemostatic agents are used to promote blood clotting and stop bleeding during and after surgical procedures
- Sealing: Surgical sealants are used to close incisions or wounds and to prevent leaks from sutures
- Bone and Tissue Repair: Biosurgery products like bone graft substitutes and soft tissue management solutions can help stimulate the body's healing process, facilitating the repair or regeneration of bone and soft tissues
- Adhesion Prevention: Adhesion barriers are used to prevent the formation of scar tissue adhesions that can cause complications after surgery
Benefits of biosurgery include:
- Improved Healing: Biosurgery products can enhance the body's natural healing process, leading to faster recovery times and better surgical outcomes.
- Reduced Complications: By controlling bleeding, preventing adhesions, and facilitating tissue repair, biosurgery can help to reduce the risk of complications associated with surgery.
- Minimized Surgical Intervention: Biosurgery products can often be applied minimally invasively, reducing the need for more extensive surgical intervention and associated risks.
- Versatility: Biosurgery products can be used in a wide range of surgical specialties, including orthopaedics, cardiovascular surgery, general surgery, and neurosurgery, among others.
Biosurgery Market Segmentations
The market can be categorised into product, application, end user, and region.Market Breakup by Product
- Bone-Graft Substitutes
- Soft-Tissue Attachment
- Haemostatic Agents
- Surgical Sealants and Adhesives
- Adhesion Barriers
- Staple Line Reinforcement
Market Breakup by Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Others
Market Breakup by Therapy Type
- Hospitals
- Clinics
- Others
Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Biosurgery Market Scenario
- The global biosurgery market is projected to experience significant growth in the upcoming years. This surge is primarily driven by factors such as the rising geriatric population, increasing number of surgeries, higher incidence of severe trauma injuries, and the growing prevalence of chronic diseases like cancer and cardiovascular disorders
- Biosurgery involves the use of various natural or synthetically produced biological materials, including surgical sealants, haemostatic agents, bone graft substitutes, and adhesion barriers. Each of these product segments holds a significant portion of the market, with their demand influenced by the rising need for improved wound healing, blood clotting, tissue repair, and prevention of surgical adhesions
- The technological advancements in the biosurgery sector are also fuelling the market growth. These innovations encompass the development of more efficient and effective products, designed to reduce surgical complications, and improve patient outcomes. For example, the emergence of combination products that incorporate biologics with synthetic materials and medical devices offers promising potential
- Geographically, North America holds a significant share of the biosurgery market, given its advanced healthcare system, high healthcare expenditure, and the presence of key market players. However, the Asia-Pacific region is expected to exhibit the fastest growth, owing to its improving healthcare infrastructure, rising disposable income, and increasing patient awareness
- Despite the optimistic growth prospects, the market faces some challenges. The high cost of biosurgery products can limit their accessibility, particularly in developing regions. Additionally, the stringent regulatory scenario for product approval may act as a hurdle for market expansion
Key Players in the Global Biosurgery Market
The report gives an in-depth analysis of the key players involved in the biosurgery market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:- Baxter
- BD
- Johnson & Johnson Services, Inc
- Medtronic
- B. Braun Melsungen AG
- CryoLife, Inc
- Stryker Corporation
- Integra LifeSciences Corporation
- Hemostasis, LLC
- CSL Limited
- AROA BIOSURGERY LIMITED
- TELA Bio, Inc
- Tissue Regenix
- Osiris Therapeutics, Inc.
Table of Contents
1 Preface
3 Global Biosurgery Market Overview
4 Global Biosurgery Market Landscape
5 Global Biosurgery Market Dynamics
6 Global Biosurgery Market Segmentation
7 North America Biosurgery Market
8 Europe Biosurgery Market
9 Asia Pacific Biosurgery Market
10 Latin America Biosurgery Market
11 Middle East and Africa Biosurgery Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Biosurgery Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Baxter
- Bd
- Johnson & Johnson Services, Inc.
- Medtronic
- B. Braun Melsungen AG
- Cryolife, Inc.
- Stryker Corporation
- Integra Lifesciences Corporation
- Hemostasis, LLC
- Csl Limited
- Aroa Biosurgery Limited
- Tela Bio, Inc.
- Tissue Regenix
- Osiris Therapeutics, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | April 2023 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 15.4 Billion |
| Forecasted Market Value ( USD | $ 26.8 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
